David A. Edwards - Publications

Affiliations: 
Bioengineering Harvard University, Cambridge, MA, United States 

25 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2016 Garcia-Contreras L, Padilla-Carlin DJ, Sung J, VerBerkmoes J, Muttil P, Elbert K, Peloquin C, Edwards D, Hickey A. Pharmacokinetics of Ethionamide Delivered in Spray-Dried Microparticles to the Lungs of Guinea Pigs. Journal of Pharmaceutical Sciences. PMID 27842973 DOI: 10.1016/J.Xphs.2016.09.033  0.663
2015 Garcia Contreras L, Sung J, Ibrahim M, Elbert K, Edwards D, Hickey A. Pharmacokinetics of Inhaled Rifampicin Porous Particles for Tuberculosis Treatment: Insight into Rifampicin Absorption from the Lungs of Guinea Pigs. Molecular Pharmaceutics. 12: 2642-50. PMID 25942002 DOI: 10.1021/Acs.Molpharmaceut.5B00046  0.651
2010 Muttil P, Pulliam B, Garcia-Contreras L, Fallon JK, Wang C, Hickey AJ, Edwards DA. Pulmonary immunization of guinea pigs with diphtheria CRM-197 antigen as nanoparticle aggregate dry powders enhance local and systemic immune responses. The Aaps Journal. 12: 699-707. PMID 20878294 DOI: 10.1208/S12248-010-9229-6  0.787
2010 Muttil P, Prego C, Garcia-Contreras L, Pulliam B, Fallon JK, Wang C, Hickey AJ, Edwards D. Immunization of guinea pigs with novel hepatitis B antigen as nanoparticle aggregate powders administered by the pulmonary route. The Aaps Journal. 12: 330-7. PMID 20419360 DOI: 10.1208/S12248-010-9192-2  0.775
2010 Garcia-Contreras L, Sung JC, Muttil P, Padilla D, Telko M, Verberkmoes JL, Elbert KJ, Hickey AJ, Edwards DA. Dry powder PA-824 aerosols for treatment of tuberculosis in guinea pigs. Antimicrobial Agents and Chemotherapy. 54: 1436-42. PMID 20086154 DOI: 10.1128/Aac.01471-09  0.649
2010 Lauten EH, Pulliam BL, DeRousse J, Bhatta D, Edwards DA. Gene expression, bacteria viability and survivability following spray drying of mycobacterium smegmatis Materials. 3: 2684-2724. DOI: 10.3390/Ma3042684  0.735
2010 Germishuizen WA, Venter L, Khosa A, Mudau F, Kabadi M, Schiermeier A, Edwards DA, Fourie PB. Establishing a platform for spray drying inhalable vaccines in South Africa European Cells and Materials. 19: 16.  0.332
2009 Morello M, Krone CL, Dickerson S, Howerth E, Germishuizen WA, Wong YL, Edwards D, Bloom BR, Hondalus MK. Dry-powder pulmonary insufflation in the mouse for application to vaccine or drug studies. Tuberculosis (Edinburgh, Scotland). 89: 371-7. PMID 19632897 DOI: 10.1016/J.Tube.2009.07.001  0.78
2009 Sung JC, Padilla DJ, Garcia-Contreras L, Verberkmoes JL, Durbin D, Peloquin CA, Elbert KJ, Hickey AJ, Edwards DA. Formulation and pharmacokinetics of self-assembled rifampicin nanoparticle systems for pulmonary delivery. Pharmaceutical Research. 26: 1847-55. PMID 19407933 DOI: 10.1007/S11095-009-9894-2  0.684
2009 Sung JC, Garcia-Contreras L, Verberkmoes JL, Peloquin CA, Elbert KJ, Hickey AJ, Edwards DA. Dry powder nitroimidazopyran antibiotic PA-824 aerosol for inhalation. Antimicrobial Agents and Chemotherapy. 53: 1338-43. PMID 19139288 DOI: 10.1128/Aac.01389-08  0.666
2008 Fourie PB, Germishuizen WA, Wong YL, Edwards DA. Spray drying TB vaccines for pulmonary administration. Expert Opinion On Biological Therapy. 8: 857-63. PMID 18564902 DOI: 10.1517/14712598.8.7.857  0.788
2008 Garcia-Contreras L, Wong YL, Muttil P, Padilla D, Sadoff J, Derousse J, Germishuizen WA, Goonesekera S, Elbert K, Bloom BR, Miller R, Fourie PB, Hickey A, Edwards D. Immunization by a bacterial aerosol. Proceedings of the National Academy of Sciences of the United States of America. 105: 4656-60. PMID 18344320 DOI: 10.1073/Pnas.0800043105  0.781
2008 Fiegel J, Garcia-Contreras L, Thomas M, VerBerkmoes J, Elbert K, Hickey A, Edwards D. Preparation and in vivo evaluation of a dry powder for inhalation of capreomycin. Pharmaceutical Research. 25: 805-11. PMID 17657592 DOI: 10.1007/S11095-007-9381-6  0.401
2007 Sung JC, Pulliam BL, Edwards DA. Nanoparticles for drug delivery to the lungs. Trends in Biotechnology. 25: 563-70. PMID 17997181 DOI: 10.1016/J.Tibtech.2007.09.005  0.756
2007 Pulliam B, Sung JC, Edwards DA. Design of nanoparticle-based dry powder pulmonary vaccines. Expert Opinion On Drug Delivery. 4: 651-63. PMID 17970667 DOI: 10.1517/17425247.4.6.651  0.78
2007 Garcia-Contreras L, Fiegel J, Telko MJ, Elbert K, Hawi A, Thomas M, VerBerkmoes J, Germishuizen WA, Fourie PB, Hickey AJ, Edwards D. Inhaled large porous particles of capreomycin for treatment of tuberculosis in a guinea pig model. Antimicrobial Agents and Chemotherapy. 51: 2830-6. PMID 17517845 DOI: 10.1128/Aac.01164-06  0.42
2007 Wong YL, Sampson S, Germishuizen WA, Goonesekera S, Caponetti G, Sadoff J, Bloom BR, Edwards D. Drying a tuberculosis vaccine without freezing. Proceedings of the National Academy of Sciences of the United States of America. 104: 2591-5. PMID 17299039 DOI: 10.1073/Pnas.0611430104  0.767
2006 Fiegel J, Clarke R, Edwards DA. Airborne infectious disease and the suppression of pulmonary bioaerosols. Drug Discovery Today. 11: 51-7. PMID 16478691 DOI: 10.1016/S1359-6446(05)03687-1  0.305
2005 Edwards D. Vaccination: a victim of its own success? The Journal of Small Animal Practice. 45: 535. PMID 15553189  0.308
2005 Clarke R, Katstra J, Man J, Dehaan W, Edwards D, Griel L. Pulmonary delivery of anti-contagion aerosol to diminish exhaled bioaerosols and airborne infectious disease American Journal of Infection Control. 33. DOI: 10.1016/J.Ajic.2005.04.101  0.342
2004 Edwards DA, Man JC, Brand P, Katstra JP, Sommerer K, Stone HA, Nardell E, Scheuch G. Inhaling to mitigate exhaled bioaerosols. Proceedings of the National Academy of Sciences of the United States of America. 101: 17383-8. PMID 15583121 DOI: 10.1073/Pnas.0408159101  0.345
2003 Tsapis N, Bennett D, O'Driscoll K, Shea K, Lipp MM, Fu K, Clarke RW, Deaver D, Yamins D, Wright J, Peloquin CA, Weitz DA, Edwards DA. Direct lung delivery of para-aminosalicylic acid by aerosol particles. Tuberculosis (Edinburgh, Scotland). 83: 379-85. PMID 14623169 DOI: 10.1016/J.Tube.2003.08.016  0.39
2002 Tsapis N, Bennett D, Jackson B, Weitz DA, Edwards DA. Trojan particles: large porous carriers of nanoparticles for drug delivery. Proceedings of the National Academy of Sciences of the United States of America. 99: 12001-5. PMID 12200546 DOI: 10.1073/Pnas.182233999  0.322
2002 Edwards DA, Dunbar C. Bioengineering of therapeutic aerosols. Annual Review of Biomedical Engineering. 4: 93-107. PMID 12117752 DOI: 10.1146/Annurev.Bioeng.4.100101.132311  0.337
1999 Batycky R, Nice J, Chen D, Sung J, Lipp M, Mintzes J, Dunbar C, Niven R, Edwards D. Production and characterization of large porous particles for pulmonary drug delivery Materials Research Society Symposium - Proceedings. 550: 95-100. DOI: 10.1557/Proc-550-95  0.347
Show low-probability matches.